These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38436491)

  • 21. Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.
    Tanner RM; Calhoun DA; Bell EK; Bowling CB; Gutiérrez OM; Irvin MR; Lackland DT; Oparil S; McClellan W; Warnock DG; Muntner P
    Am J Kidney Dis; 2014 May; 63(5):781-8. PubMed ID: 24388119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current antihypertensive treatment and treatment-resistant hypertension in Japanese patients with chronic kidney disease.
    Tsuchimoto A; Tanaka S; Kitamura H; Hiyamuta H; Tsuruya K; Kitazono T; Nakano T;
    Clin Exp Nephrol; 2022 Nov; 26(11):1100-1110. PubMed ID: 35927602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health care fragmentation and blood pressure control among adults taking antihypertensive medication.
    Colvin CL; Safford MM; Muntner P; Colantonio LD; Kern LM
    Am J Manag Care; 2022 Mar; 28(3):108-115. PubMed ID: 35404546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Social Determinants of Health and Incident Apparent Treatment-Resistant Hypertension Among White and Black US Adults: The REGARDS Study.
    Akinyelure OP; Jaeger BC; Safford MM; Oparil S; Carson AP; Sims A; Hannon L; Howard G; Muntner P; Hardy ST
    J Am Heart Assoc; 2024 May; 13(10):e031695. PubMed ID: 38752519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uncontrolled and apparent treatment resistant hypertension: a cross-sectional study of Russian and Norwegian 40-69 year olds.
    Petersen J; Malyutina S; Ryabikov A; Kontsevaya A; Kudryavtsev AV; Eggen AE; McKee M; Cook S; Hopstock LA; Schirmer H; Leon DA
    BMC Cardiovasc Disord; 2020 Mar; 20(1):135. PubMed ID: 32169049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertension in Chronic Kidney Disease.
    Hamrahian SM; Falkner B
    Adv Exp Med Biol; 2017; 956():307-325. PubMed ID: 27873228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
    Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
    [No Abstract]   [Full Text] [Related]  

  • 28. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008.
    Egan BM; Zhao Y; Axon RN; Brzezinski WA; Ferdinand KC
    Circulation; 2011 Aug; 124(9):1046-58. PubMed ID: 21824920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study.
    Vidal-Petiot E; Metzger M; Faucon AL; Boffa JJ; Haymann JP; Thervet E; Houillier P; Geri G; Stengel B; Vrtovsnik F; Flamant M;
    J Am Heart Assoc; 2018 Oct; 7(19):e010278. PubMed ID: 30371309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. National patterns in intensity and frequency of outpatient care for apparent treatment-resistant hypertension.
    Vemulapalli S; Deng L; Patel MR; Kilgore ML; Jones WS; Curtis LH; Irvin MR; Svetkey LP; Shimbo D; Calhoun DA; Muntner P
    Am Heart J; 2017 Apr; 186():29-39. PubMed ID: 28454830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dipping Status, Ambulatory Blood Pressure Control, Cardiovascular Disease, and Kidney Disease Progression: A Multicenter Cohort Study of CKD.
    Borrelli S; Garofalo C; Gabbai FB; Chiodini P; Signoriello S; Paoletti E; Ravera M; Bussalino E; Bellizzi V; Liberti ME; De Nicola L; Minutolo R
    Am J Kidney Dis; 2023 Jan; 81(1):15-24.e1. PubMed ID: 35709922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apparent Treatment Resistant Hypertension Among Stroke Survivors in Ghana.
    Sarfo FS; Ovbiagele B
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105401. PubMed ID: 33096498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and Predictors of Apparent Treatment-Resistant Hypertension in Real-World Populations Using Electronic Health Record-Based Data.
    Jafari E; Cooper-DeHoff RM; Effron MB; Hogan WR; McDonough CW
    Am J Hypertens; 2024 Jan; 37(1):60-68. PubMed ID: 37712350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence, phenotypic characteristics and prognostic role of apparent treatment resistant hypertension in the German Chronic Kidney Disease (GCKD) study.
    Mielke J; Trucks-Jansen H; Schurmann C; Kotsis F; Köttgen A; Schneider MP; Eckardt KU; ; Freitag DF; Eitner F; Becker MS
    J Hum Hypertens; 2023 May; 37(5):345-353. PubMed ID: 35534618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term costs in patients with chronic kidney disease treated with dapagliflozin: a retrospective cohort study.
    Dwyer JP; Agiro A; Desai P; Cremisi H
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(9):1057-1066. PubMed ID: 37540162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience.
    Marin F; Fezzi S; Gambaro A; Ederle F; Castaldi G; Widmann M; Gangemi C; Ferrero V; Pesarini G; Pighi M; Ribichini FL
    J Nephrol; 2021 Oct; 34(5):1445-1455. PubMed ID: 33481223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Apparent Treatment-Resistant Hypertension in the United States.
    Carey RM; Sakhuja S; Calhoun DA; Whelton PK; Muntner P
    Hypertension; 2019 Feb; 73(2):424-431. PubMed ID: 30580690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Intensive BP Control in CKD.
    Cheung AK; Rahman M; Reboussin DM; Craven TE; Greene T; Kimmel PL; Cushman WC; Hawfield AT; Johnson KC; Lewis CE; Oparil S; Rocco MV; Sink KM; Whelton PK; Wright JT; Basile J; Beddhu S; Bhatt U; Chang TI; Chertow GM; Chonchol M; Freedman BI; Haley W; Ix JH; Katz LA; Killeen AA; Papademetriou V; Ricardo AC; Servilla K; Wall B; Wolfgram D; Yee J;
    J Am Soc Nephrol; 2017 Sep; 28(9):2812-2823. PubMed ID: 28642330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial.
    Staessen JA; Den Hond E; Celis H; Fagard R; Keary L; Vandenhoven G; O'Brien ET;
    JAMA; 2004 Feb; 291(8):955-64. PubMed ID: 14982911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistant and undertreated hypertension in patients with chronic kidney disease: data from the PATRIOTIC survey.
    Zheng Y; Tang L; Chen X; Cai G; Li W; Ni Z; Shi W; Ding X; Lin H
    Clin Exp Hypertens; 2018; 40(8):784-791. PubMed ID: 29509105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.